Director
DIN: 07323963
Vivek Kumar Sikka is currently associated with 2 companies as Director. They serve as a Director at ASIAN MEDICAL AND RESEARCH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07323963.Vivek Kumar Sikka has previously been associated with 2 companies in roles such as Director and Additional Director.Vivek Kumar Sikka is currently involved in 1 different role. Their most recent position is with DASKSIDE SOLUTIONS PRIVATE LIMITED as a Director. The first company Vivek Kumar Sikka was appointed to as a director was ASIAN MEDICAL AND RESEARCH PRIVATE LIMITED. Vivek Kumar Sikka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vivek Kumar Sikka is currently associated with 2 companies as Director. They serve as a Director at ASIAN MEDICAL AND RESEARCH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07323963.Vivek Kumar Sikka has previously been associated with 2 companies in roles such as Director and Additional Director.Vivek Kumar Sikka is currently involved in 1 different role. Their most recent position is with DASKSIDE SOLUTIONS PRIVATE LIMITED as a Director. The first company Vivek Kumar Sikka was appointed to as a director was ASIAN MEDICAL AND RESEARCH PRIVATE LIMITED. Vivek Kumar Sikka is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
2y 1m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ASIAN MEDICAL AND RESEARCH PRIVATE LIMITED | Director | 31-Aug-2016 |
| DASKSIDE SOLUTIONS PRIVATE LIMITED | Director | 23-Feb-2023 |